Feb. 11, 2004 -- Latanoprost was more effective than timolol at lowering intraocular pressure (IOP), according to the results of a randomized crossover study published in the February issue of the ...
UPPSALA, Sweden — Latanoprost (Xalatan, Pharmacia Corp.) reduced diurnal intraocular pressure (IOP) significantly more than timolol, according to a meta-analysis of eight global randomized trials, ...
To assess the cost-effectiveness of latanoprost or timolol in glaucoma treatment in Norway, Sweden, Denmark (Scandinavia) and the United Kingdom (UK). A Markov model was constructed to perform a ...
Please provide your email address to receive an email when new articles are posted on . DIJON, France — Switching from timolol to latanoprost reduced intraocular pressure in glaucoma and ocular ...
To compare intraocular pressure (IOP) reductions with fixed-combination (FC) latanoprost/timolol once daily in the evening vsFC dorzolamide/timolol twice daily. Mean daytime IOP levels were similar at ...
As has been reported previously, [12–17] the FC was well tolerated. The most common adverse events were related to the eye and were consistent with known adverse events associated with latanoprost or ...
The evaluation committee considered evidence submitted by Santen, a review of this submission by the external assessment group (EAG), and responses from stakeholders. See the committee papers for full ...
How equitably are glaucoma medications being dispensed across a universal health care system, and how have prescribing ...
What is latanoprost used for? Latanoprost is commonly used to reduce increased pressure in the eye in people with either open-angle glaucoma or ocular hypertension. Latanoprost may also be used for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results